#subcutaneous #formulation
TREHALOSE DIHYDRATE (FOR INJECTION)
Trehalose CAS NO 6138 23 4 is highly cost-effective, injection grade, product quality in line with ChP, USP, JP, EP standards, Registered in US FDA, DMF No.034401 and 035566).

NMPA CDE registration no.: F20200000284

USFDA DMF no.: 035566

PRODUCT DESCRIPTION
Product Name D(+)-Trehalose dihydrate(For Injection)(Sterile)
Chemical Name α-D-glucopyranosyl-α-D-glucopyranoside dihydrate
CAS No. 6138-23-4
NMPA CDE registration no. F20190000452
USFDA DMF No. 34401
Quality grade Injection
Quality standards Conforms with USP, EP, JP, ChP standards
Molecular Formula C12H22O11·2H2O
Applications and examples Biological products, liposomes, vaccines, CAR-T, stem cells, diagnostic reagents, etc.
Product code O08001
Package sizes 10kg
Storage condition Stored in a cool, dark, and dry place, and transported at room temperature.

KEY BENEFITS OF D(+)-TREHALOSE DIHYDRATE (FOR INJECTION)
FDA DMF NumberDMF: 35566; CDE Record registration Number: F20200000284.

Aseptic GMP production environment, low endotoxin (<2.5IU/g), injection grade.

Widely used in biological agents such as antibody drugs(e.g. Herceptin®).

If you want to know more about long acting injectable formulation, diclofenac sodium injection formulation, diazepam injection formulation and subcutaneous formulation, please visit our website.

As a pharmaceutical excipients company, we can provide kinds of pharma excipients for sale, if you are interested, please contact us.


https://www.avt-pharma.com/products/trehalose-dihydrate-for-injection-cas-no-6138-23-4/ ↗